Beneficial and adverse effects of correction of anaemia by recombinant human erythropoietin in patients on maintenance haemodialysis.
Grützmacher
P
P
Department of Nephrology, University Hospital of Frankfurt/M., FRG.
Bergmann
M
M
Weinreich
T
T
Nattermann
U
U
Reimers
E
E
Pollok
M
M
D000740:Anemia / Q000209:etiology / Q000628:therapy*; D002986:Clinical Trials as Topic; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D010809:Physical Fitness; D011897:Random Allocation; D011994:Recombinant Proteins / Q000627:therapeutic use*; D006435:Renal Dialysis
D011994:Recombinant Proteins; D004921:Erythropoietin